Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanoma.

Proceedings of the National Academy of Sciences of the United States of America
Yonathan Lissanu DeribeLynda Chin

Abstract

PREX2 (phosphatidylinositol-3,4,5-triphosphate-dependent Rac-exchange factor 2) is a PTEN (phosphatase and tensin homolog deleted on chromosome 10) binding protein that is significantly mutated in cutaneous melanoma and pancreatic ductal adenocarcinoma. Here, genetic and biochemical analyses were conducted to elucidate the nature and mechanistic basis of PREX2 mutation in melanoma development. By generating an inducible transgenic mouse model we showed an oncogenic role for a truncating PREX2 mutation (PREX2(E824)*) in vivo in the context of mutant NRAS. Using integrative cross-species gene expression analysis, we identified deregulated cell cycle and cytoskeleton organization as significantly perturbed biological pathways in PREX2 mutant tumors. Mechanistically, truncation of PREX2 activated its Rac1 guanine nucleotide exchange factor activity, abolished binding to PTEN and activated the PI3K (phosphatidyl inositol 3 kinase)/Akt signaling pathway. We further showed that PREX2 truncating mutations or PTEN deletion induces down-regulation of the tumor suppressor and cell cycle regulator CDKN1C (also known as p57(KIP2)). This down-regulation occurs, at least partially, through DNA hypomethylation of a differentially methylated re...Continue Reading

References

Dec 8, 1995·The Journal of Biological Chemistry·P D BurbeloA Hall
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·S MatsuokaA P Feinberg
Oct 1, 1996·Nature Genetics·I HatadaT Mukai
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·F B FurnariW K Cavenee
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·G P RobertsonW K Cavenee
Aug 11, 1998·Nature Genetics·A Di CristofanoP P Pandolfi
Apr 21, 1999·Current Opinion in Cell Biology·S J LeeversM D Waterfield
Aug 10, 1999·Nature·L ChinR A DePinho
Aug 12, 2004·FEBS Letters·Sarah DonaldHeidi C E Welch
Nov 17, 2004·The Journal of Biological Chemistry·Kirsti HillLen R Stephens
May 6, 2006·Genesis : the Journal of Genetics and Development·Marcus BosenbergLynda Chin
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Liliana SoroceanuHeidi S Phillips
Oct 13, 2007·The Journal of Biological Chemistry·Adam ShutesChanning J Der
Dec 15, 2007·The EMBO Journal·Jong-Yeon ShinMichael J Higgins
Jun 25, 2009·European Journal of Human Genetics : EJHG·Rosanna WeksbergJ Bruce Beckwith
Mar 31, 2011·Biochimica Et Biophysica Acta·Edel Kavanagh, Bertrand Joseph
Mar 17, 2012·Nature Reviews. Genetics·Cédric Feschotte, Clément Gilbert
May 25, 2012·Nature·Michael F BergerLevi A Garraway
Jun 12, 2012·Molecular Cell·Hee Won YangWon Do Heo
Jul 24, 2012·Cell·Eran HodisLynda Chin
Jul 31, 2012·Nature Genetics·Michael KrauthammerRuth Halaban
Oct 4, 2012·Future Oncology·Alejandro Conde-Perez, Lionel Larue
Jan 4, 2013·Proceedings of the National Academy of Sciences of the United States of America·Matthew J DavisTitus J Boggon
Mar 30, 2013·Science·Bert VogelsteinKenneth W Kinzler
Apr 2, 2013·Cell·Levi A Garraway, Eric S Lander
Dec 25, 2013·Proceedings of the National Academy of Sciences of the United States of America·Cindy HodakoskiRamon Parsons
Dec 3, 2014·Biochimica Et Biophysica Acta·Stine Aske DanielsenRagnhild A Lothe
Feb 27, 2015·Nature·Nicola WaddellSean M Grimmond
Apr 2, 2015·Science Signaling·Sarah M MenseRamon Parsons
Jun 20, 2015·Cell·UNKNOWN Cancer Genome Atlas Network

❮ Previous
Next ❯

Citations

Apr 23, 2016·Small GTPases·Andrew P PorterAngeliki Malliri
Jun 18, 2016·Molecular & Cellular Oncology·Yonathan Lissanu Deribe
Dec 20, 2016·Oncogene·I ZandvakiliY Zheng
Feb 15, 2017·The FEBS Journal·Imanol Arozarena, Claudia Wellbrock
Jan 20, 2017·ELife·Stephen K HorriganUNKNOWN Reproducibility Project: Cancer Biology
Jan 20, 2017·ELife·Roger J Davis
Sep 29, 2018·Cancers·Laurie G HudsonAngela Wandinger-Ness
Sep 16, 2018·Current Oncology Reports·Giuseppe PalmieriUNKNOWN Italian Melanoma Intergroup (IMI)
Jul 16, 2017·Biochemical Society Transactions·Nuthasuda SrijakotreChristina A Mitchell
Jan 29, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·K F MeyerM N Hylkema
Aug 2, 2018·Biochemical Society Transactions·Victoria Casado-MedranoMarcelo G Kazanietz
Jun 7, 2018·Biochemical Society Transactions·Xosé R Bustelo
Jan 11, 2020·Frontiers in Cell and Developmental Biology·Yangfan XuXianqun Fan
Aug 28, 2020·Frontiers in Molecular Biosciences·Irene VanniPaola Ghiorzo
Apr 24, 2020·Frontiers in Cell and Developmental Biology·Maria Del Mar MaldonadoSuranganie Dharmawardhane
Mar 12, 2020·Frontiers in Cell and Developmental Biology·Mariana CookeMarcelo G Kazanietz
Aug 16, 2017·Cancer Research·Marcelo G Kazanietz, Maria J Caloca
Jul 16, 2016·Molecular Cancer Research : MCR·Meagan B RyanAdrienne D Cox
May 28, 2020·Trends in Cancer·Alexa C CannonJonathan Chernoff
Mar 25, 2021·Hematology/oncology Clinics of North America·Stephen M Ostrowski, David E Fisher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.